Login to Your Account

GSK Spin-Off Affymax Generates $20M In Private Financing Round

By Aaron Lorenzo

Monday, June 30, 2003
Affymax Inc. closed a $20 million private round of financing that coincided with the drug discovery and development firm's appointment of a new chief executive. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription